Skip to main content
An official website of the United States government
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

Diffusion Basis Spectrum Imaging of the Prostate to Accurately Diagnose Prostate Cancer

Trial Status: active

This trial examines whether diffusion basis spectrum imaging (DBSI) of prostate cancer can accurately diagnose prostate cancer. Magnetic resonance imaging (MRI) is a non-invasive method of taking pictures of the body without using radiation. This trial is being done to find out if an investigation analysis of MRI images called DBSI can be used to detect prostate cancer early and non-invasively.